- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Eliciting neutralizing antibodies with gp120 outer domain ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Urheber
-
Qin, Y.
- Beteiligte Personen und Organisationen
-
Han, DP
Takamoto, K.
Cho, MW
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-O11
- URN
-
urn:nbn:de:1111-2016080727122
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Qin, Y.
- Han, DP
- Takamoto, K.
- Cho, MW
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Retracted: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
P05-08. Eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein gp120: A strategy
Synthetic Neoglycoconjugates of Hepta‐ and Nonamannoside Ligands for Eliciting Oligomannose‐Specific HIV‐1‐Neutralizing Antibodies
Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine
NMR spectroscopy of HIV-1 gp120 outer domain
Broadly Neutralizing Antibodies for HIV Eradication
HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120
Engineered gp120 immunogens that elicit VRC01-like antibodies by vaccination
Immunogenicity of the outer domain of a HIV-1 clade C gp120
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Retracted: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
P05-08. Eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein gp120: A strategy
Synthetic Neoglycoconjugates of Hepta‐ and Nonamannoside Ligands for Eliciting Oligomannose‐Specific HIV‐1‐Neutralizing Antibodies
Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine
NMR spectroscopy of HIV-1 gp120 outer domain
Broadly Neutralizing Antibodies for HIV Eradication
HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120
Engineered gp120 immunogens that elicit VRC01-like antibodies by vaccination
Immunogenicity of the outer domain of a HIV-1 clade C gp120
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Retracted: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
P05-08. Eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein gp120: A strategy
Synthetic Neoglycoconjugates of Hepta‐ and Nonamannoside Ligands for Eliciting Oligomannose‐Specific HIV‐1‐Neutralizing Antibodies
Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine
NMR spectroscopy of HIV-1 gp120 outer domain
Broadly Neutralizing Antibodies for HIV Eradication
HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120
Engineered gp120 immunogens that elicit VRC01-like antibodies by vaccination